Tag: Bharat Biotech
In Win For India, Seven EU Countries Include Covishield Vaccine In 'green Pass'
At least seven European countries including, Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain, and Switzerland have approved the Covishield COVID-19 vaccine for 'Green Pass'.....
WHO Accepts Bharat Biotech's Covaxin For Emergency Use
The technical committee of World Health Organization (WHO) today granted Emergency Use Listing (EUL) to made in India Covid-19 vaccine Covaxin, according to sources. The committee had on October 26 sought additional clarifications from Covaxin manufacturer Bharat Biotech. ....
India's Vaccine Coverage Very Impressive: Bill Gates
Microsoft Co-founder and Bill & Melinda Gates Foundation Co-chair Bill Gates was all praise for India for development, manufacturing and distribution of Covid-19 vaccines and termed the country's vaccine coverage as "very impressive". ....
Over 60 Envoys Visit Bharat Biotech Facility In Hyderabad
Envoys of more than 60 countries on Wednesday visited a facility of Bharat Biotech which is developing Covaxin, India's first indigenous vaccine for coronavirus. ....
No Approval For Covaxin, Expert Panel Seeks More Data From Bharat Biotech
The Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for grant of emergency use approval and has asked for more information, top sources said.....
India Not Utilizing Vaccine To Full Capacity: Delhi HC
The Delhi High Court on Thursday showed apprehensions over non-utilization of coronavirus vaccine to its full capacity by the country, asserting that it is either being donated or sold off to foreign countries rather than being provided to Indians. ....
Covid-19: DCGI Approves Phase II-III Clinical Trials Of Covaxin On Children Aged 2 To 18 Years
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health Ministry said on Thursday. ....
Bharat Biotech's Intranasal Vaccine Gets Nod For Phase 2/3 Trials
India's first intranasal vaccine, being developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Research Assistance Council (BIRAC), on Friday got regulatory approval for Phase 2/3 trials. ....
WHO May Approve Bharat Biotech's Covaxin 'within 24 Hours'
The World Health Organisation is likely to grant emergency use approval to Bharat Biotech's Covaxin "within 24 hours", according to media reports on Tuesday.A ....
Australia Adds Covaxin To Its Accepted List Of Covid-19 Vaccines
Australia on Monday recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine. ....
